Refine by
Stemline Patient Enrolled Equipment & Supplies
1 equipment items found
by:Stemline Therapeutics, Inc. based inNew York, NEW YORK (USA)
SL-801’s potential ability to reversibly bind XPO1 may offer the possibility to mitigate side effects and help optimize the therapeutic index. A multicenter Phase 1 dose escalation trial of single agent SL-801 is currently enrolling patients with advanced solid ...